Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 1
1964 3
1965 3
1969 1
1971 3
1972 2
1973 1
1974 2
1975 1
1978 1
1985 1
1988 1
1989 2
1991 2
1992 1
1993 1
1996 1
1999 1
2000 1
2001 3
2002 1
2003 1
2004 5
2005 7
2006 11
2007 8
2008 16
2009 17
2010 13
2011 13
2012 11
2013 15
2014 9
2015 7
2016 7
2017 2
2018 4
2019 9
2020 11
2021 12
2022 15
2023 9
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Results by year

Filters applied: . Clear all
Page 1
A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis.
Weemering DN, Midei M, Milner P, Gopalakrishnan V, Kumar A, Dannenberg AJ, Bunte TM, Foucher J, Ingre C, Ķēniņa V, Rallmann K, van den Berg LH, van Eijk RPA. Weemering DN, et al. Among authors: foucher j. Eur J Neurol. 2023 Dec;30(12):3722-3731. doi: 10.1111/ene.16020. Epub 2023 Aug 21. Eur J Neurol. 2023. PMID: 37550954 Clinical Trial.
Catatonia: from pathology to brain imaging.
de Crespin de Billy C, Jeanjean LC, Obrecht A, Mainberger O, Foucher JR. de Crespin de Billy C, et al. Among authors: foucher jr. Lancet Psychiatry. 2021 Aug;8(8):653-654. doi: 10.1016/S2215-0366(21)00239-X. Lancet Psychiatry. 2021. PMID: 34303406 No abstract available.
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Benatar M, Hansen T, Rom D, Geist MA, Blaettler T, Camu W, Kuzma-Kozakiewicz M, van den Berg LH, Morales RJ, Chio A, Andersen PM, Pradat PF, Lange D, Van Damme P, Mora G, Grudniak M, Elliott M, Petri S, Olney N, Ladha S, Goyal NA, Meyer T, Hanna MG, Quinn C, Genge A, Zinman L, Jabari D, Shoesmith C, Ludolph AC, Neuwirth C, Nations S, Shefner JM, Turner MR, Wuu J, Bennett R, Dang H, Sundgreen C; ORARIALS-01 trial team. Benatar M, et al. Lancet Neurol. 2024 Jul;23(7):687-699. doi: 10.1016/S1474-4422(24)00134-0. Epub 2024 May 20. Lancet Neurol. 2024. PMID: 38782015 Clinical Trial.
Parakinesia: A Delphi consensus report.
Foucher JR, Bartsch AJ, Mainberger O, Vercueil L, de Billy CC, Obrecht A, Arcay H, Berna F, Clauss JME, Weibel S, Hanke M, Elowe J, Schorr B, Bregeon E, Braun B, Cetkovich M, Jabs BE, Dorfmeister T, Ungvari GS, Dormegny-Jeanjean LC, Pfuhlmann B. Foucher JR, et al. Schizophr Res. 2024 Jan;263:45-54. doi: 10.1016/j.schres.2022.09.024. Epub 2022 Nov 7. Schizophr Res. 2024. PMID: 36357299
Wernicke-Kleist-Leonhard phenotypes 
of endogenous psychoses: a review of their validity
.
Foucher JR, Gawlik M, Roth JN, de Crespin de Billy C, Jeanjean LC, Obrecht A, Mainberger O, Clauss JME, Elowe J, Weibel S, Schorr B, Cetkovich M, Morra C, Rebok F, Ban TA, Bollmann B, Roser MM, Hanke MS, Jabs BE, Franzek EJ, Berna F, Pfuhlmann B. Foucher JR, et al. Dialogues Clin Neurosci. 2020 Mar;22(1):37-49. doi: 10.31887/DCNS.2020.22.1/jfoucher. Dialogues Clin Neurosci. 2020. PMID: 32699504 Free PMC article. Review.
The polysemous concepts of psychomotricity and catatonia: A European multi-consensus perspective.
Foucher JR, Jeanjean LC, de Billy CC, Pfuhlmann B, Clauss JME, Obrecht A, Mainberger O, Vernet R, Arcay H, Schorr B, Weibel S, Walther S, van Harten PN, Waddington JL, Cuesta MJ, Peralta V, Dupin L, Sambataro F, Morrens M, Kubera KM, Pieters LE, Stegmayer K, Strik W, Wolf RC, Jabs BE, Ams M, Garcia C, Hanke M, Elowe J, Bartsch A, Berna F, Hirjak D. Foucher JR, et al. Eur Neuropsychopharmacol. 2022 Mar;56:60-73. doi: 10.1016/j.euroneuro.2021.11.008. Epub 2021 Dec 20. Eur Neuropsychopharmacol. 2022. PMID: 34942409 Review.
[INFORMATION ON DRUGS].
Foucher JP. Foucher JP. J Int Bioethique Ethique Sci. 2015 Mar;26(1):65-72, 101-2. J Int Bioethique Ethique Sci. 2015. PMID: 26606769 French.
Real-world effectiveness studies of low doses of antipsychotics.
Berna F, Schorr B, Javelot H, Dormegny-Jeanjean LC, Foucher JR. Berna F, et al. Among authors: foucher jr. Lancet Psychiatry. 2022 Jul;9(7):536. doi: 10.1016/S2215-0366(22)00107-9. Lancet Psychiatry. 2022. PMID: 35717954 No abstract available.
Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial - CADOT.
Dormegny-Jeanjean LC, de Billy C, Mainberger O, Weibel S, Schorr B, Obrecht A, Landré L, Berna F, Causin JB, Blanc F, Danila V, Tomsa M, Pfleger G, Meyer C, Humbert I, Javelot H, Meyer G, Bertschy G, Foucher JR. Dormegny-Jeanjean LC, et al. Among authors: foucher jr. Front Psychiatry. 2023 Sep 27;14:1194090. doi: 10.3389/fpsyt.2023.1194090. eCollection 2023. Front Psychiatry. 2023. PMID: 37829759 Free PMC article.
[Mood disorders: When should we use repetitive transcranial magnetic stimulation?].
Bulteau S, Guirette C, Brunelin J, Poulet E, Trojak B, Richieri R, Szekely D, Bennabi D, Yrondi A, Rotharmel M, Bougerol T, Dall'Igna G, Attal J, Benadhira R, Bouaziz N, Bubrovszky M, Calvet B, Dollfus S, Foucher J, Galvao F, Gay A, Haesebaert F, Haffen E, Jalenques I, Januel D, Jardri R, Millet B, Nathou C, Nauczyciel C, Plaze M, Rachid F, Vanelle JM, Sauvaget A. Bulteau S, et al. Among authors: foucher j. Presse Med. 2019 Jun;48(6):625-646. doi: 10.1016/j.lpm.2019.01.012. Epub 2019 May 31. Presse Med. 2019. PMID: 31155435 Review. French.
217 results